Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 28 for “"RNA-based therapeutics"”.
-
RNA-based therapeutics for Alzheimer's disease
… describes the development and delivery of novel RNA-based therapeutics for AD.</p> <p>Recently, significant advances have occurred in the field of RNA interference (RNAi)-based therapeutics, allowing targeted silencing of disease-relevant genes through the use of short interfering RNAs (siRNAs) …
-
Duchenne muscular dystrophy: RNA-based therapeutics and microRNA biology
… investigations into the role of small non-coding RNAs in both DMD pathology, and as potential therapeutic molecules.</p> <p>MicroRNAs (miRNAs) are a class of small RNAs that regulate gene expression and are implicated in wide-ranging cellular processes and pathological conditions. This study has …
-
Deciphering the RNA secondary structure landscape of human genes
Ribonucleic acids (RNAs) are key macromolecules that play essential roles in almost every aspect of biology. One of the most critical roles it plays is in post-transcriptional regulation of gene expression, which is primarily influenced by folding of RNA into secondary and tertiary structure. As …
-
Leveraging cell type-specific genetic associations to discover biological pathways for Crohn's disease
… leaving them unleveraged. Additionally, current therapeutics for Crohn’s disease are not equally effective across patients, underscoring the need for a better understanding of disease biology. This thesis aims to identify causal biology in immune cells from a genetics-led perspective, ultimately …
-
Bioconjugation strategies for oligonucleotide functionalisation
… analysis of biodistribution in antisense and RNA-based therapeutics. Recent development of modified nucleoside phosphoramidites and triphosphates enables the incorporation of modified functionalities and small-molecule conjugates onto synthetic oligos by solid-phase or enzymatic syntheses. …
-
DEVELOPMENT OF AN IN VIVO MULTITASKING BIOLUMINESCENT REPORTER GENE PLATFORM FOR THE PRECLINICAL EVALUATION OF RNA THERAPEUTICS
RNA-based therapeutics have emerged as a transformative class of medicines, enabling precise modulation of gene expression through sequence-defined mechanisms and offering novel therapeutic opportunities for previously intractable diseases. The potential of these drugs to address unmet …
-
Micelles and lipid nanoparticles: catalysis and biomedical application.
RNA-based therapeutics is a rapidly expanding field due to its enormous potential for treatment of diseases through knockdown of genes or expression of therapeutic proteins. However, due to the overall negative-charge of an RNA molecule, RNA-based therapeutics must rely on delivery systems to …
-
Intercellular transport of RNA can limit heritable epigenetic changes
RNAs in circulation carry sequence-specific regulatory information between cells in animal, plant, and host-pathogen systems. The accumulation of specific RNA species in circulation during human disease states therefore implicates such RNAs in disease-related gene regulation. However, mechanisms of …
-
Development of a covalent mRNA circularization strategy for light-triggered late-stage activation of translation
The success of mRNA vaccines during the COVID-19 pandemic emphasized the potential of RNA-based therapeutics. A major limitation of mRNA, however, is the short half-life. Rapid degradation in cells leads to transient protein expression characterized by a short-lived peak. While 5′ cap and 3′ …
-
The Development of Different Strategies Using Clinically Translatable Models for the Treatment of Triple Negative Breast Cancer
… the way for potential clinical application. RNA based therapeutics have emerged as a promising alternative in cancer treatment due to higher specificity in targeting key drivers of tumorigenesis. Using NPs as a delivery system, I showed the successful delivery of mRNA agents in PDX models, …
-
Targeted gene delivery in brain tumors with microbubble enhanced focused ultrasound
… of brain tumors remains an unmet need. While RNA-based therapies offer several advantages over conventional approaches, their effective delivery to brain tumors remains a major challenge due to the vascular, interstitial, and cellular barriers of the brain. Although the incorporation of RNA …
-
Computational Methods for Discovery and Analysis of RNA Structural Motifs
Understanding the 3D structural properties of RNAs will play a critical role in identifying their functional characteristics and designing new RNAs for RNA-based therapeutics and nanotechnology. In an attempt to achieve a better insight into RNAs, biochemical experiments have been conducted to …
-
MITOCHONDRIAL NDUFA4 IS A FUNCTIONAL SWITCH CONTROLLING TUMOR-ASSOCIATED MACROPHAGES AND TUMOR IMMUNITY
… of the NDUFA4 homolog NDUFA4L3 and the microRNA miR-147, both encoded by a single highly conserved bifunctional transcript. Notably, repression of NDUFA4 is necessary for the expansion of IFN-TAMs and subsequent anti-tumor immunity via NK and CD8+ T cell recruitment, whereas constitutive …
-
Microfluidics for throughput scalable formulation of mRNA lipid nanoparticle technology
… encapsulate nucleic acids, such as messenger RNA (mRNA), and deliver them intracellularly for therapeutic and vaccine applications. However, a challenge towards the broad application of LNPs for mRNA therapeutics and vaccines is the development of formulation strategies that accommodate the …
-
Intracellular Traits of Chimeric tRNAlys3-ribozymes and their Inhibition of HIV
Host tRNALYs3is the primer recruited by HIV-1 for initiating reverse transcription. When ribozymes targeted upstream of the primer binding site of the HIV-1 genome are tethered to the 3' end of the tRNALYs3, it is expected that the tRNA will carry the ribozymes into the virions. We made constructs …
-
Understanding mRNA Degradation and Improving mRNA Stability and Translation with Deep Learning
… by the rapid development of messenger RNA based vaccines for COVID-19, messenger RNA-based therapeutics hold incredible potential. Nevertheless, global distribution of mRNA vaccines worldwide has been hampered by their thermal instability, because of the inherent chemical instability of …
-
Engineering a regulatory framework for synthetic self-amplifying RNA circuits
Self-amplifying RNA replicons are an attractive alternative to traditional nucleic acid therapeutics, providing high, sustained expression from a low dose, without the risk of genomic integration. Replicons are derived from a viral genome, but utilize viral self-amplification to produce …
-
Developing RNA therapies to modulate the levels of plasminogen activator inhibitor 1
… inhibitors have stalled in clinical trials. RNA-based therapeutics offer an alternative, as they can regulate expression of proteins not amenable to traditional therapies. We developed a therapeutic approach to induce long-lasting PAI-1 knockdown in vivo with siRNA-lipid nanoparticles …
-
Design and optimisation of nanoparticle systems for the effective delivery of RNA therapeutics
… cells. Gene silencing via short interfering RNA (siRNA) provides a precise strategy for targeting cancer causing genes, with fewer side effect. Despite its potential, the successful therapeutic application of siRNA depends heavily on the development of effective delivery systems that can …
-
Probing the interactions that drive RNA binding and self-association of hnRNPA1 implicated in neurodegeneration
… includes a low-complexity domain (LCD) and two RNA-recognition motifs (RRMs), and their interdomain coordination may play a crucial role in A1 aggregation. Previous studies propose that RNA-inhibitors or nucleoside analogs that bind to RRMs can potentially prevent A1 self-association. Therefore …
Page 1 of 2